| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0762 |
| Trial ID | ChiCTR1800018059 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | The PD-1 expression reduced by shRNA technology CD19 chimeric antigen receptor T cells (CAR-T) cells in the therapy of relapse or refractory lymphoma. |
| Year | 2018 |
| Country | China |
| Company sponsor | Tianjin First Central Hospital |
| Cohort 1 | |||||||
|
|||||||